IP Library Granted Patent US 6,846,485
Granted Patent B2
US 6,846,485 · App. 10/036,371 · Granted Jan 25, 2005

Fish serine proteinase and their pharmaceutical and cosmetic use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,846,485
App. No.
10/036,371
Granted
Jan 25, 2005
Kind
B2
Abstract

Fish derived serine proteinases including trypsins and chymotrypsin derived from cod such as Atlantic cod is used for treating and/or preventing a variety of diseases and disorders such as inflammatory diseases, infectious diseases caused by viruses, bacteria and fungal species and diseases where a receptor binding mechanism is involved in the pathogenesis. Pharmaceutical and cosmetic compositions comprising the proteinases are described.

Claims (10)

1. A method of treating a disease selected from the group consisting of arthritis, tendinitis, phlebitis, psoriasis, acne, eczema, dermatitis, and wounds in a human or animal, the method comprising administering to said human or animal a pharmaceutically effective amount of a serine proteinase obtained from Atlantic cod.

2. The method according to claim 1 , wherein the proteinase is a trypsin.

3. The method according to claim 2 , wherein the trypsin is selected from the group consisting of tiypsin I, trypsin II and trypsin III.

4. The method according to claim 1 , wherein the proteinase is administered topically.

5. The method according to claim 1 , wherein the proteinase is administered gastroenterally.

6. A method of removing dead or peeling skin from otherwise healthy skin, comprising administering a pharmaceutically effective amount of a serine proteinase obtained from Atlantic cod.

7. The method according to claim 6 , wherein the proteinase is a trypsin.

8. The method according to claim 7 , wherein the trypsin is selected from the group consisting of trypsin I, trypsin II and trypsin III.

9. The method according to claim 6 , wherein the proteinase is not multifunctional.

10. The method according to claim 6 , wherein the proteinase is administered topically.

Priority Claims (1)
IS 508699 · Jun 18, 1999 · national
Continuity (2)
Division 0941168800 · Oct 12, 1999
Related Publication 20020141987A1 · Oct 3, 2002